Insulin Resistance: TOP 5 Questions for A Clinical Setting

Insulin resistance, which occurs when cells become less sensitive to insulin stimulation, can occur as early as 10 years before progressing to prediabetes. As such, insulin resistance is the earliest laboratory indicator of type 2 diabetes (T2D), cardiovascular disease and other adverse health conditions. 

This document answers the top 5 questions about insulin resistance, covering what the condition is and how to test for it, which patients should be tested, and the best ways to interpret results.

    Please keep me informed on products and services from Quest Diagnostics.

    All information that you supply is protected by our Privacy Policy.
    In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
    By submitting your information you agree to our Terms of Use.
    Third party cookies may be placed, to serve more relevant ads when you browse the web.
    You can learn more about those ads here.

    By selecting the “yes” option when filling out the above form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and opt-out and information removal. Once your information has been processed by Illumina, communication preferences and opt-out can be managed directly on the Illumina website. For more information, please refer to the Illumina privacy policy.